Management Change2 Nov 2026, 08:21 pm
Innovassynth Reappoints Dr. Hardik Joshipura as MD & CEO for 3 Years
AI Summary
Innovassynth Technologies (India) Ltd announced the Board of Directors' approval for the re-appointment of Dr. Hardik Joshipura as Managing Director & CEO. The reappointment is for a further term of three years, commencing from February 12, 2027, to February 11, 2030. This decision is subject to the approval of the company's shareholders. Dr. Joshipura, who holds a Ph.D. in Organic Chemistry and an Executive MBA from Harvard Business School, has extensive experience in leadership roles at various pharmaceutical and chemical companies.
Key Highlights
- Dr. Hardik Joshipura re-appointed as MD & CEO.
- Term extended for three years from Feb 12, 2027.
- Shareholder approval is required for the reappointment.
- Dr. Joshipura has a strong academic and professional background.
Price Impact
More from INOVSYNTH